152 related articles for article (PubMed ID: 2454067)
1. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
Bever CT; McFarland HF; Levy HB; McFarlin DE
Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
[TBL] [Abstract][Full Text] [Related]
2. A comparison of interferon responses to poly ICLC in males and females.
Bever CT; McFarlin DE; Levy HB
J Interferon Res; 1985; 5(3):423-8. PubMed ID: 2414373
[TBL] [Abstract][Full Text] [Related]
3. The kinetics of interferon induction by poly ICLC in humans.
Bever CT; McFarland HF; McFarlin DE; Levy HB
J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
[TBL] [Abstract][Full Text] [Related]
4. Preliminary trial of poly ICLC in chronic progressive multiple sclerosis.
Bever CT; Salazar AM; Neely E; Ferraraccio BE; Rose JW; McFarland HF; Levy HB; McFarlin DE
Neurology; 1986 Apr; 36(4):494-8. PubMed ID: 3960323
[TBL] [Abstract][Full Text] [Related]
5. A preliminary trial of poly(I,C)-LC in multiple sclerosis.
McFarlin DE; Bever CT; Salazar AM; Levy HB
J Biol Response Mod; 1985 Oct; 4(5):544-8. PubMed ID: 2416885
[TBL] [Abstract][Full Text] [Related]
6. Phase I-II trials of poly(ICLC) in malignant brain tumor patients.
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
J Interferon Res; 1982; 2(1):1-4. PubMed ID: 6180095
[TBL] [Abstract][Full Text] [Related]
7. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
[TBL] [Abstract][Full Text] [Related]
8. Treatment of recurrent laryngeal papillomatosis with an artificial interferon inducer (poly ICLC).
Leventhal BG; Kashima H; Levine AS; Levy HB
J Pediatr; 1981 Oct; 99(4):614-6. PubMed ID: 7277106
[No Abstract] [Full Text] [Related]
9. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits.
Levy HB; Lvovsky E
J Infect Dis; 1978 Jan; 137(1):78-81. PubMed ID: 624854
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
[TBL] [Abstract][Full Text] [Related]
11. Liver enzyme abnormalities after poly ICLC infusions.
Hess WA; Bever CT; McFarlin DE
Cancer Treat Rep; 1985 Nov; 69(11):1342. PubMed ID: 2418967
[No Abstract] [Full Text] [Related]
12. [Antitumor effect of Corynebacterium parvum and poly ICLC on experimental brain tumors].
Kiya K; Kitaoka T; Okamoto H; Harada K; Uozumi T; Toge T; Hattori T; Machida H
Neurol Med Chir (Tokyo); 1983 Nov; 23(11):841-8. PubMed ID: 6201759
[No Abstract] [Full Text] [Related]
13. A comparison of interferon responses to poly ICLC in males and females.
Bever CT; McFarlin DE; Levy HB
J Interferon Res; 1992 May; Spec No():85-90. PubMed ID: 1379290
[TBL] [Abstract][Full Text] [Related]
14. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
[No Abstract] [Full Text] [Related]
16. Topical polyriboinosinic-polyribocytidylic acid complex in the treatment of recurrent genital herpes.
Crane LR; Levy HB; Lerner AM
Antimicrob Agents Chemother; 1982 Mar; 21(3):481-5. PubMed ID: 7049075
[TBL] [Abstract][Full Text] [Related]
17. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Loewen KG; Derbyshire JB
Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
[TBL] [Abstract][Full Text] [Related]
18. Response of mouse tumor to interferon inducer and radiation.
Lvovsky EA; Mossman KL; Levy HB; Dritschilo A
Int J Radiat Oncol Biol Phys; 1985 Sep; 11(9):1721-5. PubMed ID: 4030439
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).
Rettenmaier MA; Berman ML; DiSaia PJ
Gynecol Oncol; 1986 Jul; 24(3):359-61. PubMed ID: 3721308
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
Kende M
J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]